A detailed history of Nissay Asset Management Corp transactions in Bio Techne Corp stock. As of the latest transaction made, Nissay Asset Management Corp holds 18,815 shares of TECH stock, worth $1.34 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
18,815
Previous 18,251 3.09%
Holding current value
$1.34 Million
Previous $1.31 Million 15.0%
% of portfolio
0.01%
Previous 0.01%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$70.96 - $82.35 $40,021 - $46,445
564 Added 3.09%
18,815 $1.5 Million
Q2 2024

Aug 14, 2024

BUY
$62.12 - $84.15 $13,231 - $17,923
213 Added 1.18%
18,251 $1.31 Million
Q1 2024

May 15, 2024

BUY
$65.98 - $77.09 $17,484 - $20,428
265 Added 1.49%
18,038 $1.27 Million
Q4 2023

Feb 14, 2024

BUY
$52.83 - $78.22 $45,169 - $66,878
855 Added 5.05%
17,773 $1.37 Million
Q3 2023

Nov 14, 2023

BUY
$67.52 - $89.42 $40,849 - $54,099
605 Added 3.71%
16,918 $1.15 Million
Q2 2023

Aug 14, 2023

SELL
$73.76 - $85.98 $21,759 - $25,364
-295 Reduced 1.78%
16,313 $1.33 Million
Q1 2023

May 15, 2023

SELL
$71.62 - $86.62 $36,955 - $44,695
-516 Reduced 3.01%
16,608 $1.23 Million
Q4 2022

Feb 14, 2023

BUY
$80.67 - $352.29 $1.03 Million - $4.5 Million
12,775 Added 293.75%
17,124 $1.42 Million
Q3 2022

Nov 14, 2022

BUY
$282.54 - $391.85 $46,054 - $63,871
163 Added 3.89%
4,349 $1.24 Million
Q2 2022

Aug 15, 2022

SELL
$322.67 - $449.65 $63,565 - $88,581
-197 Reduced 4.49%
4,186 $1.45 Million
Q1 2022

May 16, 2022

BUY
$353.85 - $487.79 $44,585 - $61,461
126 Added 2.96%
4,383 $1.9 Million
Q4 2021

Feb 14, 2022

BUY
$456.15 - $525.06 $16,877 - $19,427
37 Added 0.88%
4,257 $2.2 Million
Q3 2021

Nov 10, 2021

BUY
$444.87 - $538.88 $66,730 - $80,832
150 Added 3.69%
4,220 $2.05 Million
Q2 2021

Aug 13, 2021

BUY
$387.35 - $450.26 $1.58 Million - $1.83 Million
4,070 New
4,070 $1.83 Million

Others Institutions Holding TECH

About BIO-TECHNE Corp


  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $2.8B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track Nissay Asset Management Corp Portfolio

Follow Nissay Asset Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nissay Asset Management Corp , based on Form 13F filings with the SEC.

News

Stay updated on Nissay Asset Management Corp with notifications on news.